Shares of Novartis India settled with a gain of 1.77 per cent at Rs 650.25 on the BSE. During the day, it rose by 5.48 per cent to Rs 674.
CCI approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis as it did not find the transaction to be anti-competitive in India.
The multi-layered deal involves UK-based GlaxoSmithKline (GSK) acquiring the Swiss major's vaccine business while the latter would purchase GSK's cancer drugs portfolio.
Meanwhile, in the broader market the BSE benchmark Sensex ended at 27,208.61, down 297.85 points.